Animals were 8 week-old C3H/He mice derived charles-Riber Co., Ltd. A spontaneous fibrosarcoma in the C3H/He mouse, FSIIa were used throughout. Single-cell suspensions were prepared by trypsinization and the number of viable tumor cells was counted by the trypan blue exclusion method. Approximately 1x10
5 unstained cells in 5 μl of a single cell suspension were transplanted into the right footpad. Hyperthermia was given in a water bath where a desire temperature ±0.1 °C was maitained by a constant temperature circulator. Each animal was kept in an individual holder with a short arm where the animal leg was gently taped. Animal holders were placed on a achlyl plate which had holes through which animal legs were immersed into the water bath.
Human recombinant TNF (Asahikasei Industrial Co., Ltd.) were used. TNF were administered intratumorally just before the hyperthermia treatment. Tumor response was examined by tumor growth time analysis. Tumors were treated when they reached an average diameter of 8 mm. Three diameters of the tumor, a, b and c, were measured at least 3 times a week and the tumor volume was calculated by πx a xb xc/6. The TG time was obtained on a graph. Six to 8 mice were used in each dose.
Dose of TNF do not influenced to tumor growth curve.
Greater growth tumor inhibition was obtained after TNF 1000 unit + Heat (44 °C, 10 min) than TNF 1000 unit + RT 10 Gy.
Thermal sensitizing effects of TNF was remarkable in higher temperature.
View full abstract